Opportunity

Simpler Grants.gov #NOT-HD-25-007

NICHD HIV Pediatric, Adolescent, and Maternal Clinical Trials Network Funding Opportunity

Buyer

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Posted

June 25, 2025

Respond By

March 25, 2026

Identifier

NOT-HD-25-007

NAICS

541715

NICHD, a part of the National Institutes of Health, is preparing to fund research focused on HIV in pediatric, adolescent, and maternal populations. - Government Buyer: - Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health - Purpose: - Establish a clinical trials network for HIV research involving infants, children, youth, young adults, and maternal populations - Support collaborative clinical trials addressing HIV, comorbidities, and coinfections - Funding Details: - Estimated total program funding: $30,000,000 - Approximately two cooperative agreement awards (UM2 activity code) - Eligibility: - Open to government entities, businesses, educational institutions, and nonprofits - Products/Services: - No specific OEMs, vendors, or product/service line items identified; focus is on research collaboration and innovation - Notable Requirements: - Emphasis on collaborative, multi-site clinical research - No unique technical product requirements specified

Description

The Eunice Kennedy Shriver National Institute of Child Health and Human Development plans to publish a Notice of Funding Opportunity to solicit applications for research on high-priority HIV studies targeting infants, children, youth, young adults, and maternal populations. The initiative aims to establish an HIV clinical trials network focused exclusively on pediatric and maternal populations to conduct collaborative clinical trials addressing HIV and related comorbidities and coinfections. Applications are not currently being solicited; this notice provides potential applicants time to develop collaborations and projects. The NOFO will use the UM2 activity code and encourages investigators with expertise in chronic and infectious diseases, pediatrics, adolescent medicine, laboratory innovation, and cost-effectiveness to consider applying.

View original listing